The Atlas Arteria Ltd (ASX: ALX) share price is in focus after the company reported Q2 2026 toll revenue was broadly stable year-on-year, with a 0.3% dip excluding FX, and announced a new A$150 million corporate debt facility.

Image source: Getty Images
What did Atlas Arteria report?
- Q2 2026 proportionate toll revenue down 0.3% vs Q2 2025, excluding FX; down 8.1% on a reported basis
- APRR Group traffic down 3.9%, toll revenue down 1.4%
- A79 traffic steady, toll revenue up 3.3% to EUR 11.1 million
- Chicago Skyway traffic up 4.7%, toll revenue up 6.2% to USD 38.4 million
- Dulles Greenway traffic up 5.3%, toll revenue up 5.0% to USD 22.8 million
- New A$150 million 3-year term loan to fund US settlement and replenish cash reserves
What else do investors need to know?
Fuel prices had a notable impact on light vehicle traffic in France, especially for APRR and ADELAC, though heavy vehicle traffic remained resilient thanks to strong trade. Traffic was bolstered for Atlas Arteria's US and German assets, particularly due to roadworks that redirected vehicles onto their roads.
The group secured a new A$150 million debt facility, adding to its undrawn A$50 million working capital line. Proceeds will complete a US$100 million settlement related to the Chicago Skyway and strengthen the group's liquidity.
What did Atlas Arteria management say?
Chief Executive Officer Hugh Wehby said:
This quarter showed the benefits of our geographic and asset diversification, with solid traffic growth in the US and Germany largely offsetting challenging conditions in France. The new debt facility further supports our balance sheet and strategic flexibility as we continue to deliver value for our investors.
What's next for Atlas Arteria?
Atlas Arteria plans to focus on operational improvements to offset higher fuel prices and enhance performance across its portfolio. Continued execution of its capital management strategy and completion of planned roadworks on US highways are expected to support traffic levels.
The company will monitor macroeconomic and fuel price trends, while maintaining flexibility through its refreshed funding arrangements.
Atlas Arteria share price snapshot
Over the past 12 months, Atlas Arteria shares have declined 2%, trailing the S&P/ASX 200 Index (ASX: XJO), which has risen 3% over the same period.